Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 3.7B | 3.7B | 3.6B | 3.7B |
| Cost of revenue | 2.3B | 2.4B | 2.3B | 2.2B |
| Gross profit | 1.4B | 1.3B | 1.3B | 1.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 1.4B | 1.3B | 1.3B | 1.5B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 210M | 204M | 203M | 201M |
| Other income expense | 42M | -67M | 40M | 43M |
| Pretax income | 1.2B | 1.1B | 1.1B | 1.3B |
| Tax provision | 292M | 263M | 280M | 316M |
| Net income | 893M | 886M | 846M | 996M |
| Basic EPS | — | — | 0.4 | 0.5 |
| Diluted EPS | — | — | 0.4 | 0.5 |
| Basic average shares | — | — | 2.0B | 2.0B |
| Diluted average shares | — | — | 2.0B | 2.0B |
| EBITDA | 1.8B | 1.8B | 1.7B | 1.9B |
| Net income from continuing op. | 893M | 886M | 846M | 996M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |